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Abstract: A novel and sensitive HPLC- UV method has been developed for the simultaneous determination of twelve major
compounds in Longdan Xiegan Pill. The chemical profile of the twelve compounds, including geniposidic acid (1),
geniposide(2), gentiopicroside(3), liquiritin(4), crocin(5), baicalin(6), wogonoside(7), baicalein(8), glycyrrhizic acid
(9), wogonin(lO), oroxylin A(11) and aristolochic acid A(l2), was acquired using high-performance liquid
chromatography-diode array detector coupled with an electrospray tandem mass spectrometer (HPLC-DAD-ESI-MS).
The analysis was performed on a Dikma Platisil ODS CIS column (250 mm x 4. 6 mm, 5 fJ-m) with a gradient solvent
system of acetonitrile-O. 1% aqueous formic acid. The validation was carried out and the linearities (r > O. 9996),
repeatability (RSD<1.8%), intra- and inter-day precision (RSD<1.3%), and recoveries (ranging from 96.6% to
103.4%) were acceptable. The limits of detection (LOD) of these compounds ranged from 0.29 to 4.17 ng. Aristolochic
acid A, which is the toxic ingredient, was not detected in all the batches of Longdan Xiegan Pill. Furthermore,
hierarchical cluster analysis was used to evaluate the variation of the herbal prescription. The proposed method is simple,
effective and suitable for the quality control of this traditional Chinese medicine (TCM).
Keywords: Longdan Xiegan Pill; high-performance liquid chromatography-diode array detector coupled with an electros-
pray tandem mass spectrometer (HPLC-DAD-ESI-MS); qualitative evaluation; aristolochic acid A; hierarchical cluster
analysis
1 Introduction
Traditional Chinese medicines (TCMs) , which have been
used to prevent and cure diseases in China for centuries, are
becoming more and more popular around the world during
the last decade. Particular attention has been focused on
their efficacy and safety. Systematic research on TCMs has
centered on identification of chemical components, phar-
maceutical activity, processing methods, and quality
control. Great progress has been made in the quality con-
trol of TCMs, stemming mainly from modern separation
and characterization techniques. Quality control is one of
the problems for the application and development of
TCMs, which was recognized by the World Health Organi-
zation in the document entitled "General Guidelines for
Methodologies on Research and Evaluation of Traditional
Medicines".
Longdan Xiegan Pill (LXP) is one of the most popular
traditional Chinese medicine prescriptions for treatment of
jaundice, cystitis, conjunctival congestion, earache, scro-
tum and extremitas inferior eczema as well in Chinese tradi-
tional medication [1]. The chemical components of some
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ingredient herbs in LXP were iridoidal glycosides,
f1avonoids, pigments, triterpenoids, and volatile oils,
organic acids, amino acids, and inorganic compounds
[2-5]. LXP consists of 10 medicinal materials including
Radix Gentianae, Radix Scutellariae, Fructus Gardeniae,
Radix Glycytthizae, Rhizoma Alismatis, Radix Angelicae
Sinensis, Radix Rehmanniae, Semen Plantaginis, Radix Bu-
pleuri and Caulis Akebiae.
However, many cases of Longdan Xiegan Pill inducing
nephropathy have been reported in the recent ten years
[6-8]. It was reported that Caulis aristolochiae manshu-
riensis (Chinese name: Guanmutong) which contains the
aristolochic acid A (AA) is the toxic ingredient in Longdan
Xiegan Pill [9-12]. AA has drawn extensive attention since
the first Belgian reported case of nephropathy in which
non-nephrotoxicity herbal Stephania tetrandra was inad-
vertently replaced by Guanmutong containing AA in the
1990s [13]. Since 2000, the USA (FDA. , 2001) as well as
many other countries such as UK (MARA, 2003), Canada
(Canada, 2002), the Netherlands (Martena et al. , 2007),
Australia (TGA, 2001) and New Zealand (Medsafe, 2003)
has issued warnings and limited or prohibited the imports and
sales of herbs containing or suspected of containing AA,
induding Longdan Xiegan Pill and Guanmutong. To prevent
further cases of aristolochic acid related nephropathy, the
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government of China has also called for manufacturers of
Longdan Xiegan Pill to change Guanrnutong back into
Mutong (Chinese Pharmacopoeia Committee, 2002). Due to
aliasing application of Mutong and Guanrnutong in Longdan
Xiegan Pill, AA, which has been characterized as a carcin-
ogen and nephrotoxin, must be detected. Till now, the
safety of Longdan Xiegan Pill in the present market has not
been investigated in the literature available.
In the present work, an efficient high-performance liquid
chromatography-diode array detector coupled with an elec-
trospray tandem mass spectrometer (HPLC-DAD-ESI-MS)
method was proposed for the identification and quantifica-
tion of the twelve major compounds in sixteen batches of
Longdan Xiegan Pill. At the same time AA, which is
recognized as the toxic ingredient in Longdan Xiegan Pill,
was detected. Then based on the sample data, hierarchical
cluster analysis was utilized for qualitative evaluation on the
resemblance and difference of tested samples.
2· Experimental
2.1 Otemicals and materials
HPLC-grade acetonitrile and formic acid were purchased
from Merck (Darmstadt, Germany). Deionized water was
prepared by a Milli-<1o SP Reagent Water System (Bed-
ford, MA, USA) for preparing samples and mobile solu-
COOR5t>HO~
tion. Other reagents were of analytical grade. All solvents
were filtered through 0.22 flm membrane filters before
analysis.
The reference standards of geniposide, gentiopicroside,
liquiritin, baicalin, baicalein, wogonin, and aristolochic
acid A were obtained from the Chinese Institute for the
Control of Pharmaceutical and Biological Products (Bei-
jing, China); geniposidic acid was purchased from Shang-
hai Xibao Medical Science Co., Ltd. (Shanghai, China);
glycyrrhizic acid and wogonoside were purchased from
Shanghai Ronghe Medical Science Co., Ltd. (Shanghai,
China); crocin was purchased from Chengdu Man Si Te
Medical Science Co., Ltd. (Chengdu, China); wogonin
and oroxylin A were purchased from Shanghai Yousi Medi-
cal Science Co., Ltd. (Shanghai, China). The purities of
all the standards were not less than 98% (Figure 1). Six-
teen batches of LXP were collected from different pharma-
ceutical companies in China (Table 1).
2.2 Standard solutions and sample preparation
Each accurately weighed standard was dissolved in metha-
nol, respectively, and then a mixed methanolic stock solu-
tion of standards was prepared. A set of standard solutions
were prepared by appropriate dilution of the stock solution
with methanol, in order to make the calibration curve. All
the solutions were stored at 4 ·C in refrigerator.
t
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Figure 1 Structures of the twelve major constituents in LXP
Thble 1 Summary of the tested samples of LXP
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No.
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
Sample
Tongren Tang
Tongren Tang
Tongren Tang
Tongren Tang
Tongren Tang
He Nan Xing Yuan
Shan Xi Wan Hui
He Nan Bai Nian Kang Xin
Luo Yang Shun Shi
Luo Yang Shun Shi
Shi lia Zhuang Hai Tian
Yao Du
Shan Xi Xiang lu
Guang Zhou Zhong Yi
Liao Ning lin Dan
Ha Yao Shi Yi Tang
Source
Beijing, China
Beijing, China
Beijing, China
Beijing, China
Beijing, China
Henan, China
Shanxi, China
Henan, China
Henan, China
Henan, China
Hebei, China
Hebei, China
Shanxi, China
Guangdong, China
Liaoning, China
Heilongjiang, China
Batch No.
8083078
8083109
8083143
9083021
9083088
0805260
080501
20080601
20090401
20081101
20080501
080501
080302
L00004
20080111
0810114
Dosage form
Water-honeyed pill
Big honeyed pill
The water-honeyed pills of LXP were powdered to a
homogeneous size by a mortar, and sieved through a No. 40
mesh sieve. 2 g of pulverized samples and 4 g of big
honeyed pills (Batch No. 20080111 and 0810114) were
accurately weighed, transferred into 25 mL volumetric
flask, ultrasonically extracted at room temperature with
75% methanol for 1 hour, and then made up to volume.
The obtained solution was filtered through a 0.22 f.lm
syringe filter.
2.3 Analytical method
An Agilent-1100 HPLC system with diode array detector
was coupled with an LC/MSD Trap XCT electrospray ion
mass spectrometer (Agilent Corporation, MA, USA)
equipped with quaternary pump, vacuum degasser,
autosampler, column heater-cooler (Agilent Corporation,
MA, USA). The chromatographic separation was per-
formed on a Dikma ODS Cs column (250 mm x 4. 6 mm,
5 f.lm) with the column temperature set at 25°C. The mo-
bile phase consisted of acetonitrile (A) and O. 1% (v/v)
formic acid (B) with a linear gradient: 0 -10 min, 5%-
20% A; 10 - 25 min, 20% - 30% A; 25 - 40 min, 30%-
50% A; 40 - 50 min, 50% - 70% A. The flow rate was
1.0 mUmin, and the injection volume was 10 f.lL. The ana-
lytes were monitored at 254 nm. By solvent splitting, 0.2
mUmin portion of the column effluent was delivered into
the ion source of the mass spectrometer.
LC-MS detection was performed directly after UV-DAD
measurements. Analyses were performed using an LC/MSD
Trap XCT mass spectrometer (Agilent Corporation, MA,
USA) equipped with an ESI source. The ESI-MS spectra
were acquired both in positive and negative ion modes. The
MS conditions were as follows: collision energy (Ampl),
1.0 V; collision gas, He; drying gas N2 , 8 Umin; temper-
ature, 350 °C ; pressure of nebulizer, 30 psi; BY voltage, 3. 5
kV; scan range, 100 - 1 200 u; target mass, 350 u; smart
parameter setting, active. Data acquisition was performed
using Chemstation software (Agilent Corporation, MA,
USA).
3 Results and discussion
3. 1 Optimization of the chromatographic conditions and
extraction
Because of the existence of acidic ingredients in LXP
extraction, a small amount of acid was added into the
mobile phase which could inhibit the ionization of these
components to improve the peak shape and restrain the
peak tailing. Zero%, 0.1% and 0.2% aqueous formic acid
and acetic acid solutions were compared. The results
showed that all compounds could be baseline separated
when 0.1 % aqueous formic acid solution was selected.
DAD detection was employed at wavelength range of
190 - 400 nm to investigate the UV spectra of the twelve
reference compounds. It was found that 254 nm was the
best wavelength for the detection because almost all the
investigated constituents had the maximum absorption there
(Figure2B, C, and D).
Prior to sample analysis the extraction procedure was
optimized. 2.0 g samples were extracted with water, 5%
methanol, 30% methanol, 50% methanol, 75% methanol,
methanol and ethanol to analyze the effect of the solvent on
extraction efficiency. Investigating the dependence of the
yield on the extraction solvents, it was found that using 25
mL 75% methanol was the best result. Investigating the
dependence of the yield on the duration of the extraction
(15, 30, 60 and 90 min), it was found that all the
investigated compounds were almost completely extracted
when 60 min extraction was used.
3.2 Identification of the bioactive markers in LXP
In the HPLC-ESVMS spectra, most of investigated com-
pounds exhibited their quasi-molecular ions [2M + H] + , [M
+ H] + , [M + Na] + in positive ion mode and [2M-H] - or
[M-H] - in negative ion mode. Fragment ions obtained by
the loss of hexose [M-162]- , H20 [M-18]+ and CO, could
also be observed in the MS" spectra. On the basis of the MS
and UV spectra and comparison of the chromatographic
retention times with those of authentic standards, the 11
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compounds were identified in 16 batches of U~P. All the patterns as previously reported (Thble 2) [14-21].
investigated compounds showed typical fragmentation
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figure 2 HPLC-OAD chromatDgnlms. (A) HPLC-UV chromatograms of twelve major mixed standards in LXP; (B) HPLC-UV chro-
matogram of LXP with the detcction at 254 run; (C) HPLCUV chromatDgnlm of LXP with the detection at 280 run; (0) HPLCUV
chromatogram of LXP with the detection at 320 om: geniposidic acid(I). geniposide(2), gcntiopicroside(3), liquiritin(4). crocin(5).
baicalin(6), wogonoside(7). baicalein(8), glycyrrhizic acid(9), wogonin(IO), oroxylin A(ll), and aristolochic acid A (12).
'ThbIe 2 Chromatographic, UV and mass spe<:tral data of the 12 compounds analyzed by HPLCOAD-ESI-MS"
No. [R(min) 1+ )ESl-MS'( "I,) ( )ES~MS'(mlz) I_10m) IdmtiflC:;um
MS MS' MS MS'
1 9.3 373 1M-HI 2ll,123 247 G<nip<>idicacid
2 14.1 389IM+HI+ 249 775 12M-HI-, 3471M-HI- 225,123 240 G<nip<>ide
3 14.4 357IM+HI+ 195,171,149 204,243,215 GcnriopicroOde
4 20.0 835 12M-HI-, 417IM-HI- 255,135 220 Liquiritin
5 24.6 11100 IM+Na!+ 675,583,347 976 1M-fIr 651,327,283,234 230 Crocin
6 27.6 447IM+HJ+ 271,253,225 891 12M-HI-, 445IM-HI- 651 217,277,316 Baicalin
7 33.1 461IM+HJ+ 285.270,240,391 919 [2M-Hr ' 4S9!M-IW 139,283 274 W~de
8 39.2 271 [M+HI+ 241 247,274.323 Baialein
9 39.9 823IM+HI+ 669.454.408,390.189 249 Glycyrrhizic acid
111 46.0 2831M-IW 268, 239,223,212 277 Wogmin
11 47.2 283 1M-fIr 268,239,223 227,270,317 Oroxylin A
12 48.5 3421M+IW 324,298,296 3401M-Hr 241 Ari~lochK: acid A
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The molecular weight of AA was 341, with the fragment
ion [M-H] - at m/z 340 and the fragment ion [M + H] + at
m/z 342 in the mass spectra. The major fragment ions in
the MS2 spectra of AA were at m/z 324 by losing an ~O
unit ([M+ H-~O]+), m/z 298 by losing a CQ unit ([M+
H-CQ r ) and m/z 296 by losing an NQ unit ([ M + H-
NQ ]+) [22]. But AA in all samples was not detected by
extracting its molecularion and fragment ions.
3.3 Validation of the quantitative analysis
3.3.1 Linearity, limit of detection and limit of quantification
The linear calibration curves were constructed with at least
six different concentrations of chemical markers. Each
concentration was analyzed in triplicate. The limit of
detection (LOD) and limit of quantification (LOQ) were
measured on the basis of the signal- to- noise ratio of 3 and
10 as criteria, respectively. Good linear correlation and
high sensitivity under these chromatographic conditions
were confirmed by the correlation coefficients (r >
0.9996), LOD was O. 29 - 4. 17 ng, and LOQ was O. 97 -
12.50 ng (Table 3).
'Thble 3 Linear regression data, LOD and LOQ of the 12 compounds
Analyte
Linear regression data LOD (ng) LOQ (ng)
Regressive equation Test range (flg/mL) r
Geniposidic acid y=6.86x-1O.38 2.07-310.50 0.9999 1.24 4.96
Geniposide y=7.79x+1.08 2.51-376.50 1.000 1.07 3.73
Gentiopicroside y=10.61x+14.45 2.47 - 370. 50 0.9996 1.05 2.89
Liquiritin Y=5.93x + 0.05 1.47-220.50 1.000 4.17 12.50
Crocin y=5.89x-3.77 1. 39 - 208. 50 0.9999 1. 77 3.54
Baicalin y=13.45x-0.53 2.46 - 369.00 1.000 1.05 3.14
Wogonoside y =17.66x + 0.73 2.43-364.50 1.000 1.03 2.58
Baicalein y=27.65x+3.99 2.44-366.00 0.9999 0.41 1.46
Glycyrrhizic acid y=7.84x-2.90 2.44-366.00 1.000 1.04 3.63
Wogonin y =25.18x + 32.98 2.90 - 435.00 1.000 0.29 0.97
Oroxylin A y =21. 97x - 13 .49 2.54 - 381. 00 1.000 0.48 1.27
Aristolochic acid A y=40.04x-22.50 2.10 - 315. 00 1.000 1.05 2.10
3.3.2 Precision and repeatability 3.3.3 Accuracy
The mixture standard solution was analyzed for six times
under the optimal conditions both within 1 day for intra-day
variation and on 3 successive days for inter-day variation to
evaluate the precision and accuracy. The intra- and inter-
day precisions were within 0.7% and 1.3%, respectively.
In order to check the repeatability, five different solutions
made from the same sample (S4) were determined. The
RSD of repeatability was less than 1. 8%. These results
indicated that the developed method had acceptable preci-
sion and repeatability (Table 4).
'Thble 4 Statistical results of precision and repeatability of the 12
compounds
Precision Repeatability
Compound Intra-day Inter-day Content RSD
(RSD, %) (RSD, %) (mglg) (%)
Geniposidic acid 0.4 1.0 0.83 1.1
Geniposide 0.4 0.9 1.66 1.3
Gentiopicroside 0.3 0.9 0.70 1.8
Liquiritin 0.3 0.6 0.36 1.2
Crocin 0.6 1.1 0.26 0.7
Baicalin 0.3 0.3 1.66 1.2
Wogonoside 0.2 0.7 0.10 1.8
Baicalein 0.7 0.8 2.91 1.3
Glycyrrhizic acid 0.3 0.7 0.77 0.8
Wogonin 0.7 1.3 0.90 0.8
Oroxylin A 0.4 0.6 0.60 0.9
Aristolochic acid A 0.5 0.6
In order to evaluate the recovery of this method, three
different concentration levels (approximately equivalent to
0.8, 1. 0 and 1. 2 times of the concentration of the matrix)
of the reference standards were added into the sample S4
(about 50% of the sample in triplicate). The solutions were
extracted and quantified as described before. The results
showed that the assay was satisfactory with the mean recov-
ery from 95.6% to 103.8% with RSD less than 1. 9% for
the 12 components (Table 5).
3.4 Sample analysis
The described method was applied to analyze the twelve
compounds in 16 batches of LXP. The variations of their
contents were great (Table 6). Among them, crocin which
comes from Fructus Gardeniae was even hardly detected in
a few samples probably because the content of this bioactive
marker was also affected by the year of the plant cultiva-
tion, harvest time, climate and environment. The content
of AA was under LOD in all the batches of Longdan
Xiegan Pill.
To further explore the relationship between different
companies, hierarchical cluster analysis was performed,
which was a multivariate analysis technique that is used to
sort samples into groups. In our study, the hierarchical
cluster analysis of samples was performed using SPSS 16.0
software (Chicago, IL, USA). The between-groups linkage
method as the amalgamation rule and the squared Euclidean
distance as metric were applied to establish clusters. Figure 3
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Thble 5 Statistical results of recovery of the 12 compounds
Compound
Geniposidic acid
Geniposide
Gentiopicroside
Liquiritin
Crocin
Baicalin
Wogonoside
Baicalein
Glycyrrhizic acid
Wogonin
Oroxylin A
Aristolochic acid A
Original Spiked
(mg) (mg)
0.84 0.65
0.84 0.86
0.85 1.05
1.68 1.35
1.66 1. 66
1.67 2.00
0.72 0.58
0.71 0.70
0.71 0.87
0.38 0.30
0.37 0.38
0.38 0.45
0.26 0.21
0.26 0.26
0.27 0.34
2.04 1.65
2.02 2.04
2.03 2.47
0.11 0.088
0.11 0.11
0.11 0.13
2.92 2.34
2.91 2.90
2.93 3.59
0.78 0.60
0.78 0.79
0.79 0.96
0.92 0.75
0.91 0.92
0.92 1.08
0.61 0.50
0.61 0.66
0.62 0.75
o 0.40
o 0.50
o 0.60
Found Recovery Mean
(mg) (%) (%)
1.51 103.1 103.4
1.73 103.4
1.94 103.8
3.06 102.2 102.5
3.35 101.8
3.74 103.5
1.28 96.6 97.6
1.40 98.6
1.56 97.7
0.67 96.7 96.6
0.74 97.4
0.81 95.6
0: 47 100.0 102.2
0.53 103.8
0.62 102.9
3.73 102.4 102.7
4.11 102.5
4.58 103.2
0.20 102.3 100.8
0.22 100.0
0.24 100.0
5.33 103.0 103.2
5.90 103.1
6.65 103.6
1.36 96.7 97.4
1.56 98.7
1.72 96.9
1.69 102.7 102.9
1.86 103.3
2.03 102.8
1.12 102.0 102.1
1.28 101. 5
1.39 102.7
0.40 100.0 100.6
0.50 100.0
0.61 101. 7
RSD
(%)
0.3
0.8
1.0
0.9
1.9
0.4
1.3
0.3
1.1
0.3
0.6
1.0
shows the resulting dendrogram, which is divided into two
main clusters. Cluster I was formed by the sample Sl - S5
and S12. The remaining 10 samples from 9 companies be-
longed to cluster n. Cluster I was branched into two sub-
groups, which indicated that the internal quality of samples
in the same company was much similar to each other. Clus-
ter II was also branched into two subgroups, which indica-
ted that same dosage form was much similar to each other.
Therefore, the supply and quality of medicinal substances
and the quality standard of preparations should be regulated
in the future to ensure the safety of LXP.
Dendrogram using Average I.inkage (Bet\\een Groups)
Rescaled Distance Cluster Combine
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Figure 3 Dendrograms of hierarchical cluster analysis for the 16 test-
ed samples of LXP. The hierarchical clustering was done by SPSS
software. Between-groups linkage method was applied, and Squared
Euclidean distance was selected as measurement.
4 Conclusion
Traditional Chinese medicine has been used for thousands
of years in China and the adverse effects of this remedy
have been said to be rare. However, with its increasing pop-
ularity In western countries, an increasing number of
adverse effects have also been observed. Some of these
adverse effects were due to the incorrect identification of
plant material.
Thble 6 Contents of the 12 compounds in the 16 samples (n =3)
Sample Content of each compound (mglg)
No. Geniposidic Geniposide Gentiopicroside Liquiritin Crocin Baicalin Wogonoside Baicalein Glycyrrhizic Wogonin Oroxylin A Aristolochic
acid acid acid A
SI 0.8S±0.01 1. 86±0.01 0.6S±0.01 0.30±0.01 0.220±0.010 O.S9±O.Ol O.lHo.Ol 2.21±0.03 0.7Ho.Ol 0.73±0.02 O.SSO±O.OlO
S2 0.72±0.02 l.73±0.02 O.S1±O.Ol 0.33±0.01 o. 220±0. 010 0.20±0.01 0.oHo.002 1.93±0.02 O.SHO.Ol 0.76±0.01 0.490±0.020
S3 0.70±0.03 1.8S±0.02 0.93±0.01 0.30±0.01 0.320±0.020 1.S6±0.02 0.3HO.Ol 1.SS±0.02 0.80±0.01 0.61±0.01 0.400±0.010
S4 0.83±0.01 1.66±0.02 O. 70±0. 02 0.36±0.01 0.260±0.010 1.66±0.02 0.10±0.02 2.91±0.03 0.7Ho.OI O. 90±0. 02 0.600±0.010
S5 0.61±0.02 1.26±0.01 0.40±0.02 0.32±0.01 0.200±0.01O 0.94±0.01 0.2Ho.OI 2.3Ho.OI 0.61±0.01 0.8HO.Ol 0.430±0.010
S6 0.31±0.01 0.63±0.03 0.83±0.04 0.4l±0.02 0.2S±0.02 0.18±0.01 o.o8±o.oOS 0.39±0.03 0.16±0.01 o.120±0. 010
S7 0.4HO.OI 1.S4±0.03 1. 13±0.02 0.25±0.01 1.1l±0.06 0.36±0.04 0.2S±0.06 0.24±0.OS o.IHo.oI 0.160±0.010
S8 0.72±0.01 2.SS±0.04 1.18±0.02 0.28±0.01 0.090±0.001 2.03±0.07 0.46±0.02 0.4Ho.02 0.42±0.01 O. S8±0. 02 0.200±0.01O
S9 1.30±0.02 1. 92±0. 02 l.33±0.02 0.30±0.01 0.070±0.OO3 3.7Ho.03 0.81±0.01 0.61±0.01 0.89±0.02 0.26±0.02 0.190±0.010
SlO 1.49±0.01 2.S2±0.02 1. 72±0.01 0.31±0.01 0.040±0.002 4.30±0.04 0.8HO.02 0.71±0.01 1.26±0.01 0.26±0.01 0.170±0.020
Sll 1.39±0.01 3.46±0.04 O. n±o.ol 0.23±0.01 2.59±0.03 0.46±0.02 0.7Ho.03 0.S8±0.02 0.48±0.02 0.180±0.01O
SI2 1.01±0.02 1.31±0.02 3.43±0.02 0.3l±0.01 0.090±0.001 1. 69±0.01 0.3Ho.Ol 1.69±0.01 I.5Ho.oI 0.SS±0.02 0.180±0.01O
S13 0.81±0.02 1.86±0.02 1.12±0.02 O.IHO.OI O.OSO±O.OOI 1. 99±0.01 0.42±0.01 0.24±0.01 0.2HO.Ol 0.13±0.01 0.080±0.003
S14 I.2HO.02 l.3S±0.02 3.02±0.02 0.21±0.01 3.8S±0.03 0.86±0.01 0.SS±0.02 0.94±0.01 0.38±0.01 0.140±0.010
SIS 2.3S±0.01 0.9S±0.02 0.01±0.004 0.08±0.002 0.030±0.001 1.l4±0.02 0.26±0.01 0.22±0.02 0.2S±0.01 0.12±0.01 0.090±0.002
SI6 3. 20±0. 01 0.S6±0.02 0.72±0.03 0.10±0.01 0.030±0.001 1.lHo.OI 0.2S±0.01 0.31±0.02 0.40±0.01 O.lS±O.Ol O.OSO±O.OOI
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In practical application, Mutong is often substituted by
nephrotoxic and carcinogenic Guanmutong by mistake. In
Guanmutong, the content of AA is found at a high level,
while in Mutong the AA is not found. We suggest that all
herbs should undergo quality controls and toxicological
studies as strict as conventional drugs.
The proposed HPLC-DAD-ESI-MS method makes it pos-
sible to evaluate the quality of the commonly used TCM
LXP through a simultaneous determination of multi-compo-
nents. This method has been successfully applied to simulta-
neously identify and quantify 11 compounds in 16 batches
LXP samples. Additionally, the method was validated for
good linearity, limit of detection, accuracy and precision.
The HPLC assay can be utilized as a suitable quality control
method for the determination of the major biologically
active ingredients in LXP.
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